Usv Pharmaceutical Corporation

Rorer Pharmaceutical Corporation

Other

Rhone-poulenc Rorer Pharmaceuticals Inc.

Usv Pharmaceutical Co.

John T Suh

Jerry W Skiles

Howard Jones

Bruce E Williams

Paul R Menard

Bernard Loev

Jeffrey N Barton

Edward S Neiss

John J Piwinski

John R Regan

Alfred Schwab

Raymond D Youssefyeh

Charles E Pendley, Ii

Kin T Yu

Robert G Pendleton

Nai-Yi Wang

Alain B Schreiber

Fu-chih Huang

Rack H Chung, Deceased

David Stevenson

Laurence L Ho

Robert C Liu

Rack H Chung

Vassil St Georgiev

James J Mencel

Robert G Pendelton

Tihamer Herczeg

Paul Menard

A cushioning assembly includes a vehicle that has at least two doors. A first shield apparatus and a second shield apparatus are each coupled to the vehicle. The first shield apparatus and the second shield apparatus are positionable to cover the doors. The first shield apparatus and the second shield apparatus shield the doors from impact damage. A pump is coupled to the vehicle. The pump is in fluid communication with the first shield apparatus and the second shield apparatus. The pump selectively inflates and deflates the first shield apparatus and the second shield apparatus. A control is provided for selectively actuating and de-actuating the pump.

Cushioning assembly

Compounds of the formula ##STR1## wherein: R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, and R.sub.7 are independently hydrogen or lower alkyl.

Cyclic amides

Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.

Treatment of conditions requiring enhanced oxygen availability of

Treatment of conditions requiring enhanced oxygen availability to

Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.

##STR1## and pharmaceutically acceptable salts thereof, wherein: Ar is phenyl, naphthyl, heteroaryl, indole, or fused arylcycloalkyl optionally substituted with hydroxy, halo, CF.sub.3, NO.sub.2, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or aryloxy;

Aryl and heteroaryl substituted cycloalkyl compounds

This invention relates to new chemical compounds having valuable pharmaceutical activity. It particularly relates to stereoisomeric compounds possessing hypotensive activity, i.e., angiotensin converting enzyme inhibitory (ACEI) activity and having the structure ##STR1## wherein R and R.sub.9 are independently hydroxy, lower alkoxy, lower alkenoxy, di(lower alkyl)amino-lower alkoxy, hydroxy-lower alkoxy, acylamino-lower alkoxy, acryloxy-lower alkoxy, aryloxy, aryloxyl-lower alkoxy, amino, lower alkylamino, di-lower alkylamino, hydroxyamino, or aryl-lower alkylamino;

N-substituted-amido-amino acids

Compounds of the formula ##STR1## wherein R and R.sub.9 are independently hydroxy or lower alkoxy,

New peptides are disclosed which have biological activity of the same type as known calcitonins and which are amide analogs of natural calcitonins.

Amide analogs of calcitonin

Compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, wherein: Ar is phenyl, naphthyl, heteroaryl, indole, or fused arylcycloalkyl optionally substituted with hydroxy, halo, CF.sub.3, NO.sub.2, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or aryloxy;

Bisarylamines

Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive,

Antihypertensive lactams

Compounds having the general structure ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are defined herein, which exhibit antihypertensive activity.

Antihypertensive derivatives

Carboxyalkyl dipeptide compounds

Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.

Growing community of inventors

Greenwich, CT, United States of America

John T Suh